Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Current Microbiology|August 2, 2012
Concomitant antibiotic and mercury resistance among gastrointestinal microflora of feral brook trout, Salvelinus fontinalisMatthew M Meredith, Erin M Parry, Justin A Guay, et al.
Human Mutation|August 16, 2013
Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (DKC1) geneJonathan K Alder, Erin M Parry, Srinivasan Yegnasubramanian, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2007
An 11-amino acid beta-hairpin loop in the cytoplasmic domain of band 3 is responsible for ankyrin binding in mouse erythrocytesMarko Stefanovic, Nicholas O Markham, Erin M Parry, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2011
Telomere length is a determinant of emphysema susceptibilityJonathan K Alder, Nini Guo, Frant Kembou, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2008
Transferable, multiple antibiotic and mercury resistance in Atlantic Canadian isolates of Aeromonas salmonicida subsp. salmonicida is associated with carriage of an IncA/C plasmid similar to the Salmonella enterica plasmid pSN254Douglas McIntosh, Michelle Cunningham, Baijing Ji, et al.
Blood|November 17, 2021
Venetoclax plus dose-adjusted R-EPOCH for Richter syndromeMatthew S Davids, Kerry A Rogers, Svitlana Tyekucheva, et al.
Science Translational Medicine|August 12, 2016
Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysemaSusan E Stanley, Dustin L Gable, Christa L Wagner, et al.
Blood Advances|March 27, 2024
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemiaPaul J Hampel, Mahesh Swaminathan, Kerry A Rogers, et al.
Blood Advances|November 15, 2024
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphomaAndrew Looka, David A Qualls, Daniel Matthews, et al.
Blood Advances|March 26, 2026
A phase I/II Study of Duvelisib plus Venetoclax in Patients with Relapsed/Refractory CLL/SLL or Richter TransformationJennifer L Crombie, Christine E Ryan, Yue Ren, et al.
Pageof 4